Federal regulations
- Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; MRESVIA (Respiratory Syncytial Virus Vaccine)April 16, 2026
FDA approves MRESVIA respiratory syncytial virus vaccine under a rare pediatric disease priority review voucher program on June 12, 2025.